Eos SENOLYTIX to Highlight Next-Generation Mitochondria-Targeted Therapeutics at 17th World Congress on Targeting Mitochondria

ConferenceNeutral

AI Analysis

Summary

Eos SENOLYTIX will present next-generation mitochondria-targeted therapeutics at the 17th World Congress on Targeting Mitochondria. This is a routine conference presentation announcement.

Importance:2/10

Sentiment:

0.00

mitochondria-targeted therapeuticsconference presentationdrug development

Related Companies

$PULM

Read the original article

Published by yahoo_finance on September 22, 2026 12:30 PM

Read Original